Skip to main content

Table 2 Total DNA, RNA and protein content in different tissues from the four groups of rats

From: Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats

 

Control

1,25D 3

STZ

STZ + 1,25D 3

Kidney

    

DNA (mg/g)

3.0 ± 0.1

2.8 ± 0.2

3.3 ± 0.5

3.4 ± 0.1ab

Protein(mg/g)

69 ± 2

120 ± 5a

134 ± 33a

153 ± 29ab

Prot/DNA (mg/mg)

18 ± 5

43 ± 2a

41 ± 10a

45 ± 10a

RNA (mg/g)

1.3 ± 0.1

1.6 ± 0.2

1.3 ± 0.3

1.7 ± 0.3

Liver

    

DNA (mg/g)

1.9 ± 0.2

1.5 ± 0.2

2.9 ± 0.6ab

2.4 ± 0.2ab

Protein(mg/g)

105 ± 19

146 ± 17a

203 ± 27ab

182 ± 15a

Prot/DNA (mg/mg)

52 ± 9

99 ± 11a

67 ± 5

76 ± 3a

RNA (mg/g)

3.9 ± 0.3

3.2 ± 0.4

3.5 ± 0.4

3.8 ± 0.2

Adipose tissue

    

DNA (mg/g)

0.2 ± 0.06

0.2 ± 0.02

0.3 ± 0.03

0.3 ± 0.04

Protein(mg/g)

5.1 ± 1

8.2 ± 0.8a

7.9 ± 0.5a

6.1 ± 1

Prot/DNA (mg/mg)

24 ± 5

47 ± 6a

25 ± 1b

20 ± 3

RNA (mg/g)

0.1 ± 0.02

0.1 ± 0.01

0.1 ± 0.03

0.1 ± 0.04

  1. Sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 μg/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3).
  2. Values are the mean ± SEM of 4–6 determinations in each group.
  3. a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; c p < 0.05 vs. STZ-rats.